We hypothesized that thromboxane A(2) (TxA(2)) receptor stimulation directly induces apoptosis in adult cardiac myocytes. To investigate this, we exposed cultured adult rat ventricular myocytes (ARVM) to a TxA(2) mimetic [1S-[1alpha,2alpha(Z),3beta(1E,3S*),4alpha]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (I-BOP) for 24 h. Stimulation with I-BOP induced apoptosis in a dose-dependent manner and was completely prevented by a TxA(2) receptor antagonist, SQ-29548. We further investigated the role of protein kinase C (PKC) in this process. TxA(2) stimulation resulted in membrane translocation of PKC-zeta but not PKC-alpha, -betaII, -delta, and -epsilon at 3 min and 1 h. The activation of PKC-zeta by I-BOP was confirmed using an immune complex kinase assay. Treatment of ARVM with a cell-permeable PKC-zeta pseudosubstrate peptide (zeta-PS) significantly attenuated apoptosis by I-BOP. In addition, I-BOP treatment decreased baseline Akt activity and its decrease was reversed by treatment with zeta-PS. The inhibition of phosphatidylinositol 3-kinase upstream of Akt by wortmannin or LY-294002 abolished the antiapoptotic effect of zeta-PS. Therefore, our results suggest that the activation of PKC-zeta modulates TxA(2) receptor-mediated apoptosis at least, in part, through Akt activity in adult cardiac myocytes.
No takes yet. Share an insight, caveat, or question.
Shizukuda et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: